Researchers followed four patients who had spinal cord injuries for five years, and two of them showed “durable evidence of neurological improvement” after treatment with the stem cell implantation, according to a Dec. 17 feature from the university. All four patients tolerated the treatments well, the study found.
With these results, researchers plan to initiate phase 2 of the trial.
The findings were published in the Dec. 17 edition of Cell Reports Medicine.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
